Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician

A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics

(2022) Monica Fadanelli et al.   Harm Reduction Journal

Comparison of virtual to in-person academic detailing on naloxone prescribing rates at three U.S. Veterans Health Administration regional networks

(2022) Mark Bounthavong et al.   INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS

Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies

(2022) Traci C. Green et al.   Substance Abuse

Academic detailing with ambulatory pharmacists to support naloxone counseling

(2021) Amanda G. Kennedy et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden

(2021) Neda J. Kazerouni et al.   DRUG AND ALCOHOL DEPENDENCE

Naloxone availability in independent community pharmacies in Georgia, 2019

(2021) Lauren Gilbert et al.   Substance Abuse: Treatment, Prevention, and Policy

Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction

(2021) Bethany A. DiPaula et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Impact of the RESPOND Toolkit on community pharmacists’ opioid safety attitudes, self-efficacy, and knowledge

(2020) Adriane N. Irwin et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches

(2020) Traci C. Green et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018

(2020) Nana Wilson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Pharmacist experiences and perspectives with Oregon’s Death with Dignity Act

(2020) Katherine A. Peters et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Exploring Patient Perceptions of Opioid Treatment Agreements in a Community Health Center Environment

(2020) Adriane N Irwin et al.   PAIN MEDICINE

Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose

(2019) Rahi Abouk et al.   JAMA Internal Medicine

Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration

(2019) Mark Bounthavong et al.   HEALTH SERVICES RESEARCH

Impact of student pharmacist–led naloxone academic detailing at community pharmacies in Texas

(2019) Kirk E. Evoy et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016

(2018) B.E. Meyerson et al.   DRUG AND ALCOHOL DEPENDENCE

A pharmacist-driven academic detailing program to increase adult pneumococcal vaccination

(2018) Aisling R. Caffrey et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Outcomes of a randomized trial evaluating two approaches for promoting pharmacy-based referrals to the tobacco quitline

(2018) Karen Suchanek Hudmon et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Naloxone Academic Detailing: Role of Community Outreach Teaching

(2018) Alaa Abd-Elsayed et al.   Current Pain and Headache Reports

Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states

(2017) Traci C. Green et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis

(2017) Mark Bounthavong et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

The availability of pharmacies in the United States: 2007–2015

(2017) Dima Mazen Qato et al.   PLoS One

Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings

(2016) J. Deanna Wilson et al.   Substance Abuse

The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting

(2015) K. Hemming et al.   BMJ-British Medical Journal

The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting

(2015) K. Hemming et al.   BMJ-British Medical Journal

Barriers to Medical Provider Support for Prescription Naloxone As Overdose Antidote for Lay Responders

(2013) Traci C. Green et al.   SUBSTANCE USE & MISUSE